ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Fundamental Analysis & Valuation

OSL:AZT • NO0010014632

23 NOK
-0.3 (-1.29%)
Last: Mar 4, 2026, 12:28 PM

This AZT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

AZT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 75 industry peers in the Biotechnology industry. AZT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. AZT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. AZT.OL Profitability Analysis

1.1 Basic Checks

  • AZT had positive earnings in the past year.
  • AZT had a positive operating cash flow in the past year.
  • AZT had positive earnings in 4 of the past 5 years.
  • AZT had a positive operating cash flow in 4 of the past 5 years.
AZT.OL Yearly Net Income VS EBIT VS OCF VS FCFAZT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • With a decent Return On Assets value of 2.17%, AZT is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • AZT has a better Return On Equity (2.32%) than 76.00% of its industry peers.
Industry RankSector Rank
ROA 2.17%
ROE 2.32%
ROIC N/A
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
AZT.OL Yearly ROA, ROE, ROICAZT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • AZT has a better Profit Margin (7.43%) than 77.33% of its industry peers.
  • AZT's Profit Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 95.42%, AZT belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AZT has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 7.43%
GM 95.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
AZT.OL Yearly Profit, Operating, Gross MarginsAZT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. AZT.OL Health Analysis

2.1 Basic Checks

  • AZT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AZT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AZT.OL Yearly Shares OutstandingAZT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AZT.OL Yearly Total Debt VS Total AssetsAZT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 33.00 indicates that AZT is not in any danger for bankruptcy at the moment.
  • AZT's Altman-Z score of 33.00 is amongst the best of the industry. AZT outperforms 98.67% of its industry peers.
  • The Debt to FCF ratio of AZT is 0.34, which is an excellent value as it means it would take AZT, only 0.34 years of fcf income to pay off all of its debts.
  • AZT's Debt to FCF ratio of 0.34 is amongst the best of the industry. AZT outperforms 92.00% of its industry peers.
  • AZT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • AZT has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. AZT outperforms 81.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Altman-Z 33
ROIC/WACCN/A
WACC8.52%
AZT.OL Yearly LT Debt VS Equity VS FCFAZT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • AZT has a Current Ratio of 16.35. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • AZT has a Current ratio of 16.35. This is amongst the best in the industry. AZT outperforms 94.67% of its industry peers.
  • A Quick Ratio of 15.45 indicates that AZT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 15.45, AZT belongs to the best of the industry, outperforming 94.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.35
Quick Ratio 15.45
AZT.OL Yearly Current Assets VS Current LiabilitesAZT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. AZT.OL Growth Analysis

3.1 Past

  • AZT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
  • The earnings per share for AZT have been decreasing by -33.29% on average. This is quite bad
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%31.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 96.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AZT will show a very strong growth in Revenue. The Revenue will grow by 35.40% on average per year.
EPS Next Y141.87%
EPS Next 2Y96.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.73%
Revenue Next 2Y22.76%
Revenue Next 3Y20.11%
Revenue Next 5Y35.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
AZT.OL Yearly Revenue VS EstimatesAZT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
AZT.OL Yearly EPS VS EstimatesAZT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

5

4. AZT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 121.05, which means the current valuation is very expensive for AZT.
  • AZT's Price/Earnings ratio is a bit cheaper when compared to the industry. AZT is cheaper than 73.33% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.03, AZT is valued quite expensively.
  • A Price/Forward Earnings ratio of 50.05 indicates a quite expensive valuation of AZT.
  • AZT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AZT is cheaper than 76.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, AZT is valued quite expensively.
Industry RankSector Rank
PE 121.05
Fwd PE 50.05
AZT.OL Price Earnings VS Forward Price EarningsAZT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • AZT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZT is cheaper than 73.33% of the companies in the same industry.
  • AZT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AZT is cheaper than 82.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 64.6
EV/EBITDA 138.39
AZT.OL Per share dataAZT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AZT's earnings are expected to grow with 96.31% in the coming years.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y96.31%
EPS Next 3YN/A

0

5. AZT.OL Dividend Analysis

5.1 Amount

  • No dividends for AZT!.
Industry RankSector Rank
Dividend Yield 0%

AZT.OL Fundamentals: All Metrics, Ratios and Statistics

ARCTICZYMES TECHNOLOGIES ASA

OSL:AZT (3/4/2026, 12:28:45 PM)

23

-0.3 (-1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners15.37%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap1.17B
Revenue(TTM)N/A
Net Income(TTM)7.66M
Analysts80
Price Target34.68 (50.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.77%
Min EPS beat(2)48.51%
Max EPS beat(2)197.03%
EPS beat(4)3
Avg EPS beat(4)315.98%
Min EPS beat(4)-269.73%
Max EPS beat(4)1288.12%
EPS beat(8)3
Avg EPS beat(8)125.03%
EPS beat(12)5
Avg EPS beat(12)89.53%
EPS beat(16)7
Avg EPS beat(16)63.69%
Revenue beat(2)1
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-13.1%
Max Revenue beat(4)2.64%
Revenue beat(8)2
Avg Revenue beat(8)-6.86%
Revenue beat(12)3
Avg Revenue beat(12)-6.52%
Revenue beat(16)5
Avg Revenue beat(16)-3.33%
PT rev (1m)3.03%
PT rev (3m)3.03%
EPS NQ rev (1m)-23.08%
EPS NQ rev (3m)-23.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.69%
Revenue NY rev (3m)-5.24%
Valuation
Industry RankSector Rank
PE 121.05
Fwd PE 50.05
P/S 11.4
P/FCF 64.6
P/OCF 53.47
P/B 3.55
P/tB 3.97
EV/EBITDA 138.39
EPS(TTM)0.19
EY0.83%
EPS(NY)0.46
Fwd EY2%
FCF(TTM)0.36
FCFY1.55%
OCF(TTM)0.43
OCFY1.87%
SpS2.02
BVpS6.47
TBVpS5.8
PEG (NY)0.85
PEG (5Y)N/A
Graham Number5.26
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 2.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 7.43%
GM 95.42%
FCFM 17.64%
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.34
Debt/EBITDA 0.7
Cap/Depr 42.8%
Cap/Sales 3.67%
Interest Coverage N/A
Cash Conversion 352.73%
Profit Quality 237.39%
Current Ratio 16.35
Quick Ratio 15.45
Altman-Z 33
F-Score7
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)231.16%
Cap/Depr(5y)215.23%
Cap/Sales(3y)11.45%
Cap/Sales(5y)9.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y141.87%
EPS Next 2Y96.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%31.1%
Revenue Next Year26.73%
Revenue Next 2Y22.76%
Revenue Next 3Y20.11%
Revenue Next 5Y35.4%
EBIT growth 1Y-75.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.43%
EBIT Next 3Y147.4%
EBIT Next 5Y114.07%
FCF growth 1Y133.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.22%
OCF growth 3Y-71.92%
OCF growth 5Y-16%

ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ

What is the fundamental rating for AZT stock?

ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL.


What is the valuation status of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for ARCTICZYMES TECHNOLOGIES ASA?

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for AZT stock?

The Earnings per Share (EPS) of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is expected to grow by 141.87% in the next year.